Published in Clin Diagn Lab Immunol on March 01, 1999
Childhood tuberculosis and malnutrition. J Infect Dis (2012) 1.16
Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis. PLoS One (2012) 0.85
A pilot study assessing the impact of a fortified supplementary food on the health and well-being of crèche children and adult TB patients in South Africa. PLoS One (2013) 0.79
The regulation of immunity to Leishmania major. Annu Rev Immunol (1995) 8.05
The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle (1991) 7.70
A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med (1990) 4.07
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology (1994) 2.61
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood (1995) 2.57
Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J (1995) 2.23
Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun (1994) 1.73
CD30 and type 2 T helper (Th2) responses. J Leukoc Biol (1995) 1.72
Vitamin A, immunity, and infection. Clin Infect Dis (1994) 1.43
CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol (1996) 1.33
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS (1994) 1.29
Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J Immunol (1997) 1.29
Structure and expression of murine CD30 and its role in cytokine production. J Immunol (1996) 1.20
CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol (1996) 1.10
CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. Leukemia (1995) 1.05
Vitamin A status and therapy in childhood pulmonary tuberculosis. J Pediatr (1997) 1.03
Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin Exp Immunol (1996) 0.92
High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints. Clin Exp Immunol (1995) 0.90
Regulation of cytokine patterns in leprosy. Ann N Y Acad Sci (1994) 0.85
Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis (2006) 2.99
Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review. Rev Infect Dis (1989) 2.09
A gene cluster involved in the utilization of both free heme and heme:hemopexin by Haemophilus influenzae type b. J Bacteriol (1995) 2.08
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis (1998) 2.08
Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures. Pediatrics (1980) 2.01
Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis (1989) 1.87
Disclosing the diagnosis of HIV in pediatrics. J Clin Ethics (2001) 1.86
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol (2000) 1.77
Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol (1996) 1.75
Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis (1990) 1.74
Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants. J Immunol (2001) 1.72
Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics (1998) 1.69
Rheumatic fever: autoantibodies against a variety of cardiac, nuclear, and streptococcal antigens. Ann Rheum Dis (1995) 1.64
Lymphocyte subsets in healthy children during the first 5 years of life. JAMA (1992) 1.64
Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J (1989) 1.53
Discontinuities in the evolution of Pseudomonas putida cat genes. J Bacteriol (1995) 1.46
Cefuroxime treatment failure and Haemophilus influenzae meningitis: case report and review of literature. Pediatrics (1989) 1.43
Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate. J Pediatr (1999) 1.43
In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b. Antimicrob Agents Chemother (1981) 1.40
Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics (1983) 1.33
Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics (1998) 1.32
Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis (2008) 1.30
Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child (2005) 1.30
Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet (1998) 1.30
Control of catechol meta-cleavage pathway in Alcaligenes eutrophus. J Bacteriol (1983) 1.30
Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol (1996) 1.24
Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B. Mol Microbiol (1991) 1.24
Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. Crit Rev Clin Lab Sci (1989) 1.24
Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr (1985) 1.21
Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis (2011) 1.20
Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics (1998) 1.20
Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children. Antimicrob Agents Chemother (1999) 1.19
Peritonsillar abscess complicating infectious mononucleosis. J Pediatr (1984) 1.18
Antibodies to alpha-interferon in a patient with systemic lupus erythematosus. J Immunol (1982) 1.17
Tumors of smooth-muscle origin in HIV-infected children. JAMA (1990) 1.17
Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr (1999) 1.14
Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J Infect Dis (1993) 1.12
Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b. Infect Immun (1990) 1.12
Enzymatic amplification of the human immunodeficiency virus in peripheral blood mononuclear cells from pediatric patients. J Infect Dis (1989) 1.12
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. J Infect Dis (1986) 1.12
Synergistic action of ampicillin and nafcillin against ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 1.07
Staphylococcus lugdunensis: an emerging cause of ventriculoperitoneal shunt infections. Pediatr Neurosurg (2001) 1.06
Inflammatory meningeal masses of unexplained origin. An ultrastructural and immunological study. J Neuropathol Exp Neurol (1983) 1.05
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants. J Infect Dis (2001) 1.04
Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J (1994) 1.03
Synergistic action of nafcillin and ampicillin against ampicillin-resistant Haemophilus influenzae type b bacteremia and meningitis in infant rats. Antimicrob Agents Chemother (1980) 1.03
Vitamin A status and therapy in childhood pulmonary tuberculosis. J Pediatr (1997) 1.03
Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis. Pediatrics (1981) 1.03
Monoclonal antibody-based solid-phase immunoenzymometric assays for quantifying human immunoglobulin G and its subclasses in serum. Clin Chem (1985) 1.03
Characterization of a TOL-like plasmid from Alcaligenes eutrophus that controls expression of a chromosomally encoded p-cresol pathway. J Bacteriol (1984) 1.02
Neurosurgical shunt infections. A review. Childs Brain (1980) 1.02
Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis (2000) 1.02
Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest (2001) 1.01
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. J Infect Dis (2001) 1.01
Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole. J Clin Invest (1982) 1.00
Successful treatment of Nocardia asteroides infection with amikacin. J Pediatr (1980) 1.00
Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr (1991) 0.98
Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections. J Pediatr (1983) 0.97
Pediatric cerebral abscess. Pediatr Neurosci (1988) 0.96
Multiple group B streptococcal infections in a premature infant: eradication of nasal colonization with rifampin. Am J Dis Child (1985) 0.96
Plasma vitamin A and zinc levels in HIV-infected adults in Cape Town, South Africa. Br J Nutr (2003) 0.95
Ventriculoperitoneal shunt infections with gram-negative bacteria. Neurosurgery (1993) 0.94
Nasopharyngeal carriage of Haemophilus influenzae type b: attempted eradication by cefaclor or rifampin. Pediatrics (1981) 0.94
Perirectal abscess in infants and children: report of 52 cases and review of literature. Pediatr Infect Dis J (1990) 0.94
Cerebrospinal fluid shunt infections: a personal view. Pediatr Infect Dis (1985) 0.94
Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes. Clin Immunol (2000) 0.93
Stimulation of NK-like CMC by skin test antigens in vitro is depressed in patients with SLE. Clin Exp Immunol (1982) 0.93
What represents pleocytosis in blood-contaminated ("traumatic tap") cerebrospinal fluid in children? J Pediatr (1985) 0.92
A comparison of commercially available adjuvants for use in research. J Immunol Methods (1992) 0.92
Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children. Pediatr Infect Dis J (1991) 0.91
Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection. J Immunol (1991) 0.91
Once daily ceftriaxone for central nervous system infections and other serious pediatric infections. Pediatr Infect Dis (1986) 0.91
Evidence for isofunctional enzymes in the degradation of phenol, m- and p-toluate, and p-cresol via catechol meta-cleavage pathways in Alcaligenes eutrophus. J Bacteriol (1984) 0.90
Rapid evolution of central nervous system lymphoma in renal transplant recipient. Lancet (1981) 0.89
Treatment of Salmonella meningitis and brain abscess with the new cephalosporins: two case reports and a review of the literature. Pediatr Infect Dis J (1987) 0.89
Wound infection following dog bite despite prophylactic penicillin. Infection (1986) 0.89
Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infection. J Infect Dis (1998) 0.89
Pulmonary paragonimiasis in Laotian refugee children. Pediatrics (1982) 0.89
Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J (2001) 0.88
Are adolescents ready for tuberculosis vaccine trials? Vaccine (2008) 0.88
Immunologic abnormalities in two patients with pulmonary hyalinizing granuloma. Am J Clin Pathol (1982) 0.87
Occupational sitting and low hip mineral density. Calcif Tissue Int (1998) 0.87
Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution. Infect Immun (1991) 0.87
Duration of illness in ambulatory children diagnosed with bronchiolitis. Arch Pediatr Adolesc Med (2000) 0.87
Treatment of pediatric infections with amikacin as first-line aminoglycoside. Am J Med (1985) 0.87
In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b. Antimicrob Agents Chemother (1982) 0.87
Quantification of human immunodeficiency virus type 1 RNA levels in plasma by using small-volume-format branched-DNA assays. J Clin Microbiol (1998) 0.86
Secretory IgA synthesis in Kwashiorkor. J Clin Lab Immunol (1983) 0.86
Phase I evaluation of zalcitabine administered to human immunodeficiency virus-infected children. J Infect Dis (1995) 0.86
A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team. Pediatrics (1998) 0.86
Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr (1990) 0.86
The 1992 measles epidemic in Cape Town--a changing epidemiological pattern. S Afr Med J (1994) 0.85
Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group. Antimicrob Agents Chemother (1998) 0.85